Myomo, Inc. – AMEX:MYO

Myomo stock price today

$1.15
-5.22
-81.95%
Financial Health
0
1
2
3
4
5
6
7
8
9

Myomo stock price monthly change

+38.78%
month

Myomo stock price quarterly change

+38.78%
quarter

Myomo stock price yearly change

+23.93%
year

Myomo key metrics

Market Cap
195.48M
Enterprise value
491.22K
P/E
-0.51
EV/Sales
0.03
EV/EBITDA
-0.04
Price/Sales
0.33
Price/Book
0.83
PEG ratio
-0.02
EPS
-0.26
Revenue
19.54M
EBITDA
-9.12M
Income
-9.33M
Revenue Q/Q
8.92%
Revenue Y/Y
29.17%
Profit margin
-68.92%
Oper. margin
-68.61%
Gross margin
65.92%
EBIT margin
-68.61%
EBITDA margin
-46.66%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Myomo stock price history

Myomo stock forecast

Myomo financial statements

Myomo, Inc. (AMEX:MYO): Profit margin
Jun 2023 5.95M -1.01M -17.02%
Sep 2023 5.07M -2.02M -39.95%
Dec 2023 4.75M -2.46M -51.72%
Mar 2024 3.75M -3.83M -102.16%
Myomo, Inc. (AMEX:MYO): Analyst Estimates
Mar 2024 3.75M -3.83M -102.16%
Sep 2025 8.1M -703.64K -8.69%
Oct 2025 9.8M 735.05K 7.5%
Dec 2025 9.9M 551.28K 5.57%
  • Analysts Price target

  • Financials & Ratios estimates

Myomo, Inc. (AMEX:MYO): Debt to assets
Jun 2023 13296992 4.47M 33.67%
Sep 2023 17053965 6.03M 35.36%
Dec 2023 14581568 5.59M 38.35%
Mar 2024 16520857 5.62M 34.02%
Myomo, Inc. (AMEX:MYO): Cash Flow
Jun 2023 -285.52K -2.96M -8.14K
Sep 2023 -1.71M -1.31M 3.94M
Dec 2023 -2.35M 2.29M 31
Mar 2024 -3.24M -3.54M 5.36M

Myomo alternative data

Myomo, Inc. (AMEX:MYO): Employee count
Aug 2023 100
Sep 2023 100
Oct 2023 100
Nov 2023 100
Dec 2023 100
Jan 2024 100
Feb 2024 100
Mar 2024 101
Apr 2024 101
May 2024 101
Jun 2024 101
Jul 2024 101

Myomo other data

32.13% +25.28%
of MYO is owned by hedge funds
2.26M +1.78M
shares is hold by hedge funds

Myomo, Inc. (AMEX:MYO): Insider trades (number of shares)
Period Buy Sel
Aug 2023 177899 0
Sep 2023 15000 0
Nov 2023 0 14997
Dec 2023 0 23330
Mar 2024 50000 0
May 2024 0 35426
Transaction Date Insider Security Shares Price per share Total value Source
Sale
KOVELMAN HARRY officer: Chief Medical Officer
Common Stock 35,426 $3.69 $130,828
Purchase
KIRK THOMAS F director
Common Stock 50,000 $3.5 $175,000
Sale
CROWLEY THOMAS ALOYSIUS JR. director
Common Stock 14,997 $4.08 $61,188
Sale
KOVELMAN HARRY officer: Chief Medical Officer
Common Stock 8,333 $3.12 $26,016
Sale
CROWLEY THOMAS ALOYSIUS JR. director
Common Stock 14,997 $3.27 $49,040
Purchase
MORRIS MILTON MAYO director
Common Stock 15,000 $1.06 $15,870
Purchase
GUDONIS PAUL R director, officer.. Common Stock 48,400 $0.75 $36,058
Purchase
KOVELMAN HARRY officer: Chief Medical Officer
Common Stock 8,333 $0.6 $5,000
Purchase
HENRY DAVID A officer: Chief Financial Officer
Common Stock 41,666 $0.6 $25,000
Purchase
GUDONIS PAUL R director, officer.. Common Stock 37,000 $0.78 $28,786
Patent
Application
Filling date: 25 Jan 2021 Issue date: 30 Sep 2021
Application
Filling date: 6 Aug 2020 Issue date: 19 Nov 2020
Application
Filling date: 6 Mar 2019 Issue date: 12 Sep 2019
Tuesday, 17 December 2024
marketbeat.com
Thursday, 5 December 2024
businesswire.com
Wednesday, 4 December 2024
businesswire.com
Wednesday, 6 November 2024
seekingalpha.com
zacks.com
Tuesday, 5 November 2024
seekingalpha.com
Wednesday, 30 October 2024
businesswire.com
Wednesday, 9 October 2024
businesswire.com
Thursday, 12 September 2024
businesswire.com
Thursday, 5 September 2024
businesswire.com
Friday, 9 August 2024
seekingalpha.com
Tuesday, 6 August 2024
businesswire.com
Wednesday, 5 June 2024
businesswire.com
Wednesday, 8 May 2024
Seeking Alpha
Wednesday, 1 May 2024
Business Wire
Sunday, 10 March 2024
Seeking Alpha
Thursday, 7 March 2024
Zacks Investment Research
Wednesday, 20 December 2023
Zacks Investment Research
Friday, 1 December 2023
Seeking Alpha
Monday, 20 November 2023
InvestorPlace
Tuesday, 7 November 2023
Seeking Alpha
Monday, 28 August 2023
InvestorPlace
Wednesday, 9 August 2023
Zacks Investment Research
Seeking Alpha
Wednesday, 5 July 2023
Zacks Investment Research
Monday, 22 May 2023
Zacks Investment Research
Wednesday, 10 May 2023
Zacks Investment Research
Monday, 13 March 2023
Zacks Investment Research
Thursday, 9 March 2023
PennyStocks
Tuesday, 7 March 2023
PennyStocks
  • What's the price of Myomo stock today?

    One share of Myomo stock can currently be purchased for approximately $1.15.

  • When is Myomo's next earnings date?

    Unfortunately, Myomo's (MYO) next earnings date is currently unknown.

  • Does Myomo pay dividends?

    No, Myomo does not pay dividends.

  • How much money does Myomo make?

    Myomo has a market capitalization of 195.48M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 23.7% to 19.24M US dollars.

  • What is Myomo's stock symbol?

    Myomo, Inc. is traded on the AMEX under the ticker symbol "MYO".

  • What is Myomo's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Myomo?

    Shares of Myomo can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Myomo's key executives?

    Myomo's management team includes the following people:

    • Mr. Paul R. Gudonis Chairman, Pres & Chief Executive Officer(age: 70, pay: $439,710)
    • Mr. David A. Henry Chief Financial Officer(age: 64, pay: $375,350)
    • Mr. Micah J. Mitchell Chief Commercial Officer(age: 49, pay: $320,610)
  • How many employees does Myomo have?

    As Jul 2024, Myomo employs 101 workers.

  • When Myomo went public?

    Myomo, Inc. is publicly traded company for more then 8 years since IPO on 12 Jun 2017.

  • What is Myomo's official website?

    The official website for Myomo is myomo.com.

  • Where are Myomo's headquarters?

    Myomo is headquartered at 137 Portland Street, Boston, MA.

  • How can i contact Myomo?

    Myomo's mailing address is 137 Portland Street, Boston, MA and company can be reached via phone at +61 79969058.

Myomo company profile:

Myomo, Inc.

myomo.com
Exchange:

AMEX

Full time employees:

101

Industry:

Medical - Devices

Sector:

Healthcare

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

137 Portland Street
Boston, MA 02114

CIK: 0001369290
ISIN: US62857J2015
CUSIP: 62857J201